This section is provided to enable you to share insights with valued colleagues
using the latest Internet communication technologies. Learn from key opinion leaders
in your field by reviewing the downloadable podcasts on key subjects of interest.
Or you can choose to sign up for the next interactive Web seminar and share insights
of your own.
To subscribe to these podcasts, copy the URL from below and paste it into your podcasting software. To download a single podcast, right-click (or option-click) one of the links below and select "Save Target As...".
Note: If you use a pop-up blocker, we recommend that you turn off the blocker before accessing the podcast links below.
Register Here for immediate access to the On-Demand Digital Replay
How to Buy an EMR
Register Here for immediate access to the On-Demand Digital Replay
Team Building: A Strategy Towards Enhanced Office Efficiency
Register Here for immediate access to the On-Demand Digital Replay
Time Management
Register Here for immediate access to the On-Demand Digital Replay
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. AMPP Advisory Group. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343-349.
Silberstein SD, for the US Headache Consortium. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Am Acad Neurol. 2000:1-11.
Snow V, Weiss K, Wall EM, Mottur-Pilson C, for the American Academy of Family Physicians and the American College of Physicians American Society of Internal Medicine. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med. 2002;137:840-849.
Hahn SR, Nelson M, Lipton RB. The language of migraine (LOM) study: frequency, impairment, and prevention in migraine communication. Poster presented at: Diamond Headache Clinic's 19th Annual Practicing Physician's Approach to the Difficult Headache Patient, February 14-18, 2006; Rancho Mirage, Calif.
Silberstein SD, Neto W, Schmitt J, Jacobs D, for the MIGR-001 Study Group. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol. 2004;61:490-495.
Brandes JL, Saper JR, Diamond M, et al, for the MIGR-002 Study Group. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291:965-973.
IMS Health, IMS LRx Longitudinal data, Topamax Monthly Tracking Report, December 2007. Custom Study conducted by IMS Management Consulting.
Adelman J, Freitag F, Lainez M, et al. Analysis of Safety and Tolerability Data Obtained from Over 1,500 Patients Receiving Topiramate for Migraine Prevention in Controlled Trials. Pain Medicine. 2007. 1526-4637
Lipton RB, Diamond M, Freitag FG, Bigal M, Stewart WF, Reed ML. Migraine prevention patterns in a community sample: results from the American Migraine Prevalence and Prevention (AMPP) Study. Poster presented at the American Headache Society meeting, 2005; Philadelphia, PA.
Health Plan Audit-Multimedia, Yardley, PA: June 8, 2007